Literature DB >> 10401742

Utility of magnetic resonance cholangiography in the evaluation of biliary obstruction.

T H Magnuson1, J S Bender, M D Duncan, S A Ahrendt, J W Harmon, F Regan.   

Abstract

BACKGROUND: Evaluation of suspected biliary obstruction has traditionally involved a variety of imaging modalities including ultrasound, CT, and invasive cholangiography. These techniques have limitations because of poor visualization of intraductal stones (ultrasound and CT) and the need for an invasive procedure (ERCP and percutaneous transhepatic cholangiography). Magnetic resonance cholangiography (MRC) is a noninvasive imaging modality that provides good visualization of the hepatobiliary system. The aim of the present study was to determine the utility of MRC in evaluating patients with suspected biliary obstruction. STUDY
DESIGN: One hundred forty-three patients were identified with suspected acute biliary obstruction and underwent MRC. Patient selection was based on clinical criteria including an elevation in serum liver chemistries or evidence of biliary ductal dilatation on conventional imaging. MRC was performed using a half-Fourier acquisition single-shot turbo spin-echo sequence involving single breath-hold rapid image acquisition. A final diagnosis was determined in each patient based on invasive cholangiography, findings at surgery, and clinical course.
RESULTS: Of the 143 patients, 73 had an obstructing biliary lesion. A malignant process was identified in 25 patients with final diagnoses of pancreatic cancer (n = 15), ampullary cancer (n = 4), cholangiocarcinoma (n = 3), and hepatic or nodal metastases (n = 3). MRC correctly identified biliary obstruction in all these patients and accurately identified the level of biliary obstruction in 24 of 25 patients. Based on the MRC images alone, a malignant process was suspected in 21 of the 25 patients. Forty patients were found to have common bile duct stones and eight patients had a benign distal bile duct stricture. MRC correctly identified common bile duct stones in 37 patients with one false-positive exam (sensitivity = 92%; specificity = 99%). MRC also correctly identified distal biliary strictures in eight patients. In the remaining 70 patients, no definite biliary obstruction was identified by MRC, and in all patients the absence of mechanical obstruction was confirmed by invasive cholangiography or overall clinical course.
CONCLUSIONS: This study demonstrates that MRC is able to accurately identify the level and cause of biliary obstruction in both malignant and benign disease. MRC may prove to be an important noninvasive tool in preoperative evaluation of patients with suspected biliary obstruction and identification of patients most likely to benefit from an invasive radiologic or surgical procedure.

Entities:  

Mesh:

Year:  1999        PMID: 10401742     DOI: 10.1016/s1072-7515(99)00082-4

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  13 in total

1.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

Authors:  S A Khan; B R Davidson; R Goldin; S P Pereira; W M C Rosenberg; S D Taylor-Robinson; A V Thillainayagam; H C Thomas; M R Thursz; H Wasan
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  Percutaneous ultrasound-guided cholangiography using microbubbles to evaluate the dilated biliary tract: initial experience.

Authors:  Zhou Luyao; Xie Xiaoyan; Xu Huixiong; Xu Zuo-Feng; Liu Guang-Jian; Lu Ming-de
Journal:  Eur Radiol       Date:  2011-09-24       Impact factor: 5.315

3.  Percutaneous endobiliary forceps biopsy of biliary strictures for histopathologic examination.

Authors:  Anne Marie Augustin; Marcus Steingrüber; Friederika Fluck; Oliver Goetze; Thorsten Alexander Bley; Ralph Kickuth
Journal:  Diagn Interv Radiol       Date:  2020-07       Impact factor: 2.630

Review 4.  [Comparison of 2D and 3D sequences for MRCP. Clinical value of the different techniques].

Authors:  A M Wallnoefer; K A Herrmann; U Beuers; C J Zech; S Gourtsoyianni; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2005-11       Impact factor: 0.635

Review 5.  Cholangiocarcinoma and its management.

Authors:  S A Khan; A Miras; M Pelling; S D Taylor-Robinson
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

6.  The case against preoperative biliary drainage with pancreatic resection.

Authors:  Rurik C Johnson; Steven A Ahrendt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

7.  Diagnosis and treatment of cholangiocarcinoma: a consensus from surgical specialists of China.

Authors:  Jian-Qiang Cai; Shou-Wang Cai; Wen-Ming Cong; Min-Shan Chen; Ping Chen; Xiao-Ping Chen; Yan-Ling Chen; Yi-Fa Chen; Chao-Liu Dai; Qiang Huang; Zhi-Yong Huang; Bo Jiang; Bin Jiang; Ke-Wei Jiang; Bo Li; Zong-Fang Li; Li-Jian Liang; Bin Liu; Hui-Chun Liu; Lian-Xin Liu; Qing-Guang Liu; Rong Liu; Ying-Bin Liu; Jian-Guo Lu; Shi-Chun Lu; Yi Lu; Yi-Lei Mao; Bin Mei; Jun Niu; Bao-Gang Peng; Xiao Qin; Yu-Dong Qiu; Guang-Yi Wang; Yao-Dong Wang; Zhi-Ming Wang; Ren-Hua Wan; Ya-Fu Wu; Bao-Cai Xing; Feng Xia; Ge-Liang Xu; Jia-Mei Yang; Xiao-Fang Yu; Yong Zeng; Yong-Yi Zeng; Bi-Xiang Zhang; Bin-Hao Zhang; Qi-Yu Zhang; Shui-Jun Zhang; Wan-Guang Zhang; Yong-Jie Zhang; Zhi-Wei Zhang; Dong Zhou; Wei-Ping Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

8.  Percutaneous imaging-guided interventions for acute biliary disorders in high surgical risk patients.

Authors:  Ragab Hani Donkol; Nahed Abdel Latif; Khaled Moghazy
Journal:  World J Radiol       Date:  2010-09-28

Review 9.  Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones.

Authors:  Vanja Giljaca; Kurinchi Selvan Gurusamy; Yemisi Takwoingi; David Higgie; Goran Poropat; Davor Štimac; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

10.  Clinical spotlight review for the management of choledocholithiasis.

Authors:  Vimal K Narula; Eleanor C Fung; D Wayne Overby; William Richardson; Dimitrios Stefanidis
Journal:  Surg Endosc       Date:  2020-02-24       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.